Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.5M Buy
31,104
+8,166
+36% +$943K 0.09% 193
2025
Q4
$2.41M Sell
22,938
-16,267
-41% -$1.53M 0.1% 212
2025
Q3
$3.29M Buy
39,205
+3,090
+9% +$255K 0.11% 179
2025
Q2
$2.86M Buy
36,115
+15,698
+77% +$1.25M 0.11% 173
2025
Q1
$1.83M Buy
+20,417
New +$1.91M 0.08% 218

Other funds holding MRK

VestGen Advisors's MRK Position: Q1 2026 in Review

VestGen Advisors increased its Merck (MRK) stake by 36% in Q1 2026, buying an estimated $943K and bringing the position to 31,104 shares worth $3.5M. The position accounts for 0.09% of the portfolio, ranked #193.

VestGen Advisors first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. 3,784 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • VestGen Advisors held 31,104 shares of Merck worth $3.5M as of Q1 2026.
  • VestGen Advisors bought 8,166 Merck shares in Q1 2026, an estimated $943K.
  • Merck made up 0.09% of VestGen Advisors's portfolio in Q1 2026, its #193 holding.
  • VestGen Advisors first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • 3,784 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on VestGen Advisors's 13F filing for Q1 2026, filed 14 May 2026.